Page 3 - Jesse Simons News Today

Solarcycle just landed $6.6 million in venture capital funding to power its giga-scale recycling ambitions.

Recent failed clinical trials of a drug designed to clear the mutant Huntingtin protein that causes Huntingtons disease (HD) heightens the need for new approaches for the devastating, incurable, progressive neurodegenerative genetic disorder. Scientists at the Buck Institute have found that the targeting the protein called FK506-binding protein 51 or FKBP51 promotes the clearing of those toxic proteins via autophagy, a natural process whereby cells recycle damaged proteins and mitochondria and u...